Launch VideoHomepage >>>
Leveraged Finance Podcast series presents: High Yield: Where’s the Value? – FREE PODCAST. Where is the relative value for investors and what are the biggest risks for the next 12 months? Featuring: Margie Patel, Senior Portfolio Manager, Wells Capital Management Gershon Distenfeld, Senior Vice President, AllianceBernstein Matthew Philo, Senior Managing Director, MacKay Shields Marty Fridson, [...]
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to review Novo Nordisk’s insulin Degludec (Tresiba) and DegludecPlus (Ryzodeg, insulin Degludec/insulin aspart) for type I and type II diabetes on Nov. 8. Read more>>
Commentary by Adam Litke When Morgan Stanley released its earnings this October it immediately came under fire for shortening the historical period used in its VaR model from four years to one year and thus lowering its capital charges. Even though the firm explained that this change had been approved by its regulators some commentators were of the opinion that there was some chicanery afoot. During their earnings [...]
Edoma Partners LLP, the hedge fund started by former Goldman Sachs Group Inc. proprietary trader Pierre-Henri Flamand, plans to close after it lost money and assets shrank. “This is very disappointing for everyone concerned,” Flamand, 42, said in an emailed statement yesterday. “Considering the unprecedented market conditions, we felt the most responsible course of action was to return money to investors and cease investment [...]
Deutsche Bank AG would be required to hold more capital and Bank of America Corp.’s burden stands to be reduced as global regulators shuffled the competitive balance among the world’s biggest banks. Citigroup Inc., HSBC Holdings Plc and JPMorgan Chase & Co. join Deutsche Bank as firms that will be targeted for a capital surcharge of 2.5 [...]
